During the past decade, Beijing Fengtai Youanmen Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Beijing Fengtai Youanmen Hospital" are "Intracerebral Hemorrhage" (1 trials), "Solid Tumors" (1 trials) and "Statins" (1 trials). Many other conditions were trialed in "Beijing Fengtai Youanmen Hospital" in a lesser frequency.

Most popular intervention types in "Beijing Fengtai Youanmen Hospital" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Statin" (1 trials) and "microtransplantation, HLA-mismatched donor peripheral stem cell infusion" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beijing Fengtai Youanmen Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Beijing Fengtai Youanmen Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Beijing Fengtai Youanmen Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Beijing Fengtai Youanmen Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".